Abiopharma

🔍 LUCKY DONALD C.I. (Executive)

Company: MYR GROUP INC. (MYRG)

Report Date: 2026-04-23

Detailed Transactions and Holdings:

• Acquired 1,160 shares of Common Stock (Direct)
  Date: 2026-04-24 | Code: M | equity_swap_involved: false | shares_owned_after: 20,808.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 554 shares of Common Stock at $339.28 per share (Direct)
  Date: 2026-04-24 | Code: F | equity_swap_involved: false | shares_owned_after: 20,254.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 414 shares of RESTRICTED STOCK UNIT (Derivative)
  Date: 2026-04-23 | Code: A | equity_swap_involved: false | shares_owned_after: 414.00 | transaction_form_type: 4 | Footnotes: F3, F3, F3
• Sold 1,160 shares of RESTRICTED STOCK UNIT (Derivative)
  Date: 2026-04-24 | Code: M | Expires: 2026-04-24 | Exercise: 2026-04-24 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: These Restricted Stock Units, which were awarded on April 24, 2025 pursuant to the Issuer's 2017 Long-Term Incentive Plan, vested on April 24, 2026 and were settled in shares of the Issuer's common stock on a one-for-one basis.
• F2: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units granted pursuant to the Issuer's 2017 Long-Term Incentive Plan.
• F3: Each Restricted Stock Unit, awarded pursuant to the Issuer's 2017 Long-Term Incentive Plan, represents a contingent right to receive one share of the Issuer's common stock. Restricted Stock Units will be converted into 414 shares of the Issuer's common stock on April 23, 2027.